Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 51

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 51
---
arrants

The
following summary of certain terms and provisions of the pre-funded warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by the provisions of, the pre-funded warrant. Prospective investors should carefully review the terms
and provisions of the form of pre-funded warrant for a complete description of the terms and conditions of the pre-funded warrants.

The
term “pre-funded” refers to the fact that the purchase price of each pre-funded warrant, at closing, will equal the
price per share at which shares of our common stock and accompanying warrants to purchase common stock are being sold to the public in
this offering, minus $0.001, and the exercise price of each pre-funded warrant will equal $0.001 per share of common stock. The purpose
of the pre-funded warrants is to enable investors that may have restrictions on their ability to beneficially own more than
4.99% (or, upon election of the holder, 9.99%) of our outstanding common stock following the consummation of this offering the opportunity
to invest capital into us without triggering their ownership restrictions, by receiving pre-funded warrants in lieu of our
common stock to the extent it would result in such ownership of more than 4.99% (or 9.99%), and receive the ability to purchase the shares
underlying the pre-funded warrants at such nominal price at a later date.

Form. Pursuant to a warrant agency agreement between us and Computershare, Inc. and Computershare Trust Company, N.A., as warrant agent, the pre-funded warrants will be issued in book-entry form and shall initially be represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC. The following is a brief summary of the pre-funded warrants and is still subject in all respect to the provisions contained in the form of pre-funded warrant.

Duration.
The pre-funded warrants offered hereby will entitle the holders thereof to purchase shares of our common stock at a nominal exercise
price of $0.001 per share, commencing immediately on the date of issuance. The pre-funded warrants do not expire.

Exercise Limitation. A holder will not have the right to exercise any portion of the pre-funded warrant if the holder (together with
its affiliates and certain related parties) would